Paper30133440
Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.
Khadir F and 8 others. PLoS Negl Trop Dis, 2018. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin. Papers, record 30133440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30133440
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leishmaniasis | Major topic |
| Morpholines | Major topic |
| Pyrimidines | Major topic |
| Quinolines | Major topic |
| Sulfonamides | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Animals | |
| Antiprotozoal Agents | |
| Enzyme Inhibitors | |
| Female | |
| Gene Expression Regulation | |
| Inhibitory Concentration 50 | |
| Mice | |
| Mice, Inbred BALB C | |
| Pyridazines | |
| Sirolimus | |
| Benzenesulfonamides |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOP-130465 | Canadian Institutes of Health Research | International | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22091408 | Use of antimony in the treatment of leishmaniasis: current status and future directions. | Mol Biol Int | 2011 | https://conductscience.org/library/papers/22091408 | PubMed |
| 2 | 9698849 | In vitro method for isolation of amastigote forms of Leishmania amazonensis from J774G8 macrophage induced by temperature shifting. | Mem Inst Oswaldo Cruz | 1998 | https://conductscience.org/library/papers/9698849 | PubMed |
| 3 | 24992200 | Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/24992200 | PubMed |
| 4 | 11748963 | A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. | Exp Parasitol | 2001 | https://conductscience.org/library/papers/11748963 | PubMed |
| 5 | 23137768 | Management of trypanosomiasis and leishmaniasis. | Br Med Bull | 2012 | https://conductscience.org/library/papers/23137768 | PubMed |
| 6 | 21342450 | Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. | Am J Transplant | 2011 | https://conductscience.org/library/papers/21342450 | PubMed |
| 7 | 3522261 | Leishmania mexicana: amastigote hydrolases in unusual lysosomes. | Exp Parasitol | 1986 | https://conductscience.org/library/papers/3522261 | PubMed |
| 8 | 16843727 | Phlebotomine sand flies and Leishmania parasites: friends or foes? | Trends Parasitol | 2006 | https://conductscience.org/library/papers/16843727 | PubMed |
| 9 | 21886855 | The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing. | PLoS Negl Trop Dis | 2011 | https://conductscience.org/library/papers/21886855 | PubMed |
| 10 | 16603397 | Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. | Mol Cell | 2006 | https://conductscience.org/library/papers/16603397 | PubMed |
| 11 | 23149671 | Isoenzyme and ultrastructural characterization of Leishmania tropica axenic amastigotes and promastigotes. | Parasitol Res | 2013 | https://conductscience.org/library/papers/23149671 | PubMed |
| 12 | 17517415 | Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. | Int J Parasitol | 2007 | https://conductscience.org/library/papers/17517415 | PubMed |
| 13 | 25800274 | CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. | Semin Immunopathol | 2015 | https://conductscience.org/library/papers/25800274 | PubMed |
| 14 | 15718470 | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. | Science | 2005 | https://conductscience.org/library/papers/15718470 | PubMed |
| 15 | 20551225 | Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20551225 | PubMed |
| 16 | 19402821 | Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). | Biochem J | 2009 | https://conductscience.org/library/papers/19402821 | PubMed |
| 17 | 21605997 | Recent advances in leishmaniasis treatment. | Int J Infect Dis | 2011 | https://conductscience.org/library/papers/21605997 | PubMed |
| 18 | 25558171 | An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. | Biostat Bioinforma Biomath | 2013 | https://conductscience.org/library/papers/25558171 | PubMed |
| 19 | 21917379 | Qualitative and quantitative polymerase chain reaction (PCR) for detection of Leishmania in spleen samples from naturally infected dogs. | Vet Parasitol | 2012 | https://conductscience.org/library/papers/21917379 | PubMed |
| 20 | 23299097 | A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. | J Vis Exp | 2012 | https://conductscience.org/library/papers/23299097 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41524558 | Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage. | Aging Cell | 2026 | https://conductscience.org/library/papers/41524558 | PubMed |
| 40643963 | PI3K/AKT signaling in parasites and parasite diseases: Role and therapeutic potential. | Virulence | 2025 | https://conductscience.org/library/papers/40643963 | PubMed |
| 39460345 | Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39460345 | PubMed |
| 39387580 | Can letrozole be repurposed for the treatment of visceral leishmaniasis? | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/39387580 | PubMed |
| 38399281 | The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38399281 | PubMed |
| 37152895 | Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37152895 | PubMed |
| 36809058 | Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis. | Appl Environ Microbiol | 2023 | https://conductscience.org/library/papers/36809058 | PubMed |
| 35992172 | Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35992172 | PubMed |
| 35757692 | Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model. | Front Immunol | 2022 | https://conductscience.org/library/papers/35757692 | PubMed |
| 34185780 | Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis. | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/34185780 | PubMed |
| 33534106 | Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions. | Drug Deliv Transl Res | 2021 | https://conductscience.org/library/papers/33534106 | PubMed |
| 33534053 | The host mTOR pathway and parasitic diseases pathogenesis. | Parasitol Res | 2021 | https://conductscience.org/library/papers/33534053 | PubMed |
| 33381110 | Systems Immunology Analysis Reveals an Immunomodulatory Effect of Snail-p53 Binding on Neutrophil- and T Cell-Mediated Immunity in KRAS Mutant Non-Small Cell Lung Cancer. | Front Immunol | 2020 | https://conductscience.org/library/papers/33381110 | PubMed |
| 32784615 | Leishmania Immunity: Advancing Immunotherapy and Vaccine Development. | Microorganisms | 2020 | https://conductscience.org/library/papers/32784615 | PubMed |
| 32517744 | Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum. | Parasit Vectors | 2020 | https://conductscience.org/library/papers/32517744 | PubMed |
| 32479529 | Translational profiling of macrophages infected with Leishmania donovani identifies mTOR- and eIF4A-sensitive immune-related transcripts. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/32479529 | PubMed |
| 32340370 | In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei. | Molecules | 2020 | https://conductscience.org/library/papers/32340370 | PubMed |
| 31707263 | Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia. | Int J Parasitol Drugs Drug Resist | 2019 | https://conductscience.org/library/papers/31707263 | PubMed |
| 31031755 | Autophagy Limits Inflammasome During Chlamydia pneumoniae Infection. | Front Immunol | 2019 | https://conductscience.org/library/papers/31031755 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| DEPTOR | 64798 | PubTator's text mining | https://conductscience.org/library/genes/64798 | NCBI Gene |
| MAPKAP1 | 79109 | PubTator's text mining | https://conductscience.org/library/genes/79109 | NCBI Gene |
| MLST8 | 64223 | PubTator's text mining | https://conductscience.org/library/genes/64223 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| RICTOR | 253260 | PubTator's text mining | https://conductscience.org/library/genes/253260 | NCBI Gene |
| RPTOR | 57521 | PubTator's text mining | https://conductscience.org/library/genes/57521 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30133440
GET https://conductscience.org/api/papers/v1/30133440/references?page=2